Texas Instruments (TXN)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-07-07
$293.30-3.36%
Close 2026-07-07 · 1-day change
Reading TXN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TXN free→NASDAQInformation TechnologySemiconductorsSnapshot 2026-07-07
Reading TXN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TXN free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a strong recent financial performance. The current thesis state is intact, supported by management's focus on revenue and earnings growth.
The market seems to have priced in a stretched valuation compared to peers, reflecting a low fragility tier. There is an expectations gap, indicating that some positive outcomes may not be fully reflected in the current valuation.
Management is on track to meet its revenue and earnings per share (EPS) targets for Q2 2026, which suggests continued strong performance. However, there is a low probability of missing estimates, but recent earnings surprises are trending down.
The long-term thesis hinges on several factors, including the potential for the Federal Reserve to cut rates and the performance of sector bellwethers like NVDA, TSM, and AVGO. Any guidance cuts from TXN could negatively impact sentiment.
Overall, TXN's fundamentals appear solid, but the stock's performance will depend on external economic factors and sector trends. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a positive outlook. Increased revenue in Q2 2026 also reinforces this view. A new product launch aligns with growth objectives.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: The earnings report will give important details about revenue and EPS. This affects how people feel about the stock.
Confirms one read:Earnings report shows strong revenue and EPS growth.
Confirms the other:Earnings report shows revenue and EPS decline.
Why it matters: Hitting this revenue target shows Texas Instruments is growing. It proves management can carry out its plan.
Confirms:Q2 2026 revenue reported at $5.00 billion or higher.
Disproves:Q2 2026 revenue reported below $5.00 billion.
Why it matters: Meeting this EPS target shows strong earnings growth and good cost control. It is a good sign for the company's finances.
Confirms:Q2 2026 EPS reported at $1.77 or higher.
Disproves:Q2 2026 EPS reported below $1.77.
Why it matters: A new CFO can change financial strategy. This may affect investor confidence and stock performance.
Confirms one read:Positive market reaction to the new CFO's first public statements or strategy.
Confirms the other:Negative market reaction or lack of confidence in the new CFO's strategy.
Why it matters: Cost savings can lower expenses and raise profits. This helps overall earnings.
Confirms one read:Management says they reached at least 75% of their cost savings goals.
Confirms the other:Management says they reached less than 50% of their cost savings goals.
Why it matters: Getting operational synergies can cut costs and improve margins. This is important for growth.
Confirms:Management says there are at least 10% savings from working together better.
Disproves:No progress on working together better was reported in Q2 2026.
Why it matters: Approval is key to finishing the acquisition and future growth.
Confirms:News of approval for the acquisition.
Disproves:News of problems or delays in getting approval.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Getting $450 million in benefits will boost profits and efficiency. It supports the reasons for the acquisition.
Confirms:Annual benefits of $450 million expected within three years after the deal.
Disproves:Benefits reported much lower than $450 million or delays in getting them.